Blog Posts

Applications are open for the PREVENT Cancer Preclinical Drug Development Program – NCI Division of Cancer Prevention

Photo taken from NCI Division of Cancer Prevention/LinkedIn

Oct 10, 2024, 18:51

Applications are open for the PREVENT Cancer Preclinical Drug Development Program – NCI Division of Cancer Prevention

NCI Division of Cancer Prevention posted the following on LinkedIn:

“The National Cancer Institute (NCI) PREVENT Cancer Preclinical Drug Development Program (PREVENT) is accepting applications to support the preclinical development of innovative interventions and predictive biomarkers for cancer prevention and interception towards clinical applications in high-risk populations. Interested researchers from academia, industry, nonprofits, and government with innovative ideas in precision cancer prevention are encouraged to apply.

Deadline: Monday, November 4, 2024.

Find out more.”

Source: NCI Division of Cancer Prevention/LinkedIn

academia Application Deadline cancer Cancer Prevention clinical applications government high-risk populations industry National Cancer Institute NCI Division of Cancer Prevention nonprofits OncoDaily Oncology precision cancer prevention predictive biomarkers PREVENT Cancer Preclinical Drug Development Program researchers

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding